Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 162

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 162
---
 Mr. Drucker was a founding member of Brainstorm (NASDAQ:
BCLI), a company publicly traded on the Nasdaq where he served as COO in 2004 and CEO from 2005 to 2007 and a founding member of Pluristem
(NASDAQ: PSTI). Mr. Drucker currently serves on the board of directors of Innocan Pharma Corporation (CSE: INNO) and Nurexone Biologic
Inc. (TSX: NRX). Mr. Drucker brings significant expertise in the management, operations, business development and product development
in start-ups. He is also involved as a consultant and co-founder of other start-ups in different fields.

The above-listed officers and directors will serve
until the next annual meeting of the stockholders or until their death, resignation, retirement, removal, or disqualification, or until
their successors have been duly elected and qualified. Vacancies in the existing Board of Directors are filled by majority vote of the
remaining Directors. Officers serve at the will of the Board of Directors.

Board Committees

The Company has not established any committees.
The entire Board participates in the nomination and audit oversight processes and considers executive and director compensation. Given
the size of the Company and its stage of development, the entire Board is involved in such decision-making processes. Thus, there is a
potential conflict of interest in that our directors and officers have the authority to determine issues concerning management compensation,
nominations, and audit issues that may affect management decisions. We are not aware of any other conflicts of interest with any of our
executive officers or directors.

Director Oversight and Qualifications

While management is responsible
for the day-to-day management of the risks the company faces, the Board, as a whole and through its committees, has responsibility for
the oversight of risk management. An important part of risk management is not only understanding the risks facing the company and what
steps management is taking to manage those risks, but also understanding what level of risk is appropriate for the company. In support
of this oversight function, the Board receives regular reports from our Chief Executive Officer and members of senior management on operational,
financial, legal, and regulatory issues and risks. The chairman of the Board and independent members of the Board work together to provide
strong, independent oversight of the company’s management and affairs through its standing committees and, when necessary, special
meetings of directors.

Family Relationships

There are no family relationships between any of our officers and directors.

<div